US SEC Form D Record
Dewpoint Therapeutics, Inc.
View External RecordSEC Filing Date
Jul 13, 2026
Capital / Financials
$82.3M Raised
Late Stage / Pre-IPO
Registered Location
BOSTON,
Legal Status
23 Backers
Industry Classification
Biotechnology
Corporate Dossier
Listed Founders / Executives
- Ameet Nathwani, M.D.
- Srinivas Akkaraju, M.D., Ph.D.
- Regina Barzilay, Ph.D.
- Olivier Brandicourt, M.D.
- Giuseppe Ciaramella, Ph.D.
- Anthony Hyman, Ph.D.
- Mark Murcko, Ph.D.
- Amir Nashat, Sc.D.
- Steven Neier, Ph.D.
- Richard Young, Ph.D.
- Isaac Klein, M.D., Ph.D.
Semantic Peers & Competitors
ROOT: BIOTECHNOLOGY
Powered by the Semantic Peer Engine. We cross-referenced the semantic root of this entity's industry class against our global SaaS, Enterprise, and SEC venture capital databases to find market parallels.
Venture Backed US
Restora Medical, Inc.
Venture Backed US
Valius Health, Inc.
SaaS Metrics